Brief: InVivo Therapeutics Announces $9 Million Registered Direct And Private Placement Offerings, Priced At-The-Market Under Nasdaq Rules
07/10/2022 13:11
Oct 7 (Reuters) - InVivo Therapeutics Holdings Corp
NVIV.O :
* INVIVO THERAPEUTICS ANNOUNCES $9 MILLION REGISTERED DIRECT
AND
PRIVATE PLACEMENT OFFERINGS, PRICED AT-THE-MARKET UNDER NASDAQ
RULES
* INVIVO THERAPEUTICS HOLDINGS CORP - PREFERRED INVESTMENT
OPTIONS
HAVE AN EXERCISE PRICE OF $5.05 PER SHARE
* INVIVO THERAPEUTICS - ENTERED INTO A DEFINITIVE AGREEMENT
FOR
SALE AND ISSUANCE OF 523,810 SHARES OF COMPANY'S COMMON STOCK
Source text for Eikon: ID:nBw7Gk6mra
Further company coverage: NVIV.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on InVivo Therapeutics Holdings
See all newsU.S. STOCKS ON THE MOVE-Gold miners, Dorian LPG, Apple
U.S. STOCKS ON THE MOVE-CMS Energy, SunPower, Etsy
InVivo Therapeutics falls on filing for Chapter 11 bankruptcy
Brief: InVivo Therapeutics Holdings Received Notice Of Delisting Or Failure To Satisfy Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Alibaba, Cisco, CRISPR